HURA · Insider Trading
TuHURA Biosciences, Inc. Common Stock
Every open-market purchase and sale reported by HURA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-29 | James A. Bianco | Chief Executive Officer | G | −150,000 | — |
| 2026-02-17 | George K Ng | Director | A | +156,240 deriv. | — |
| 2026-02-17 | James S J Manuso | Director | A | +156,240 deriv. | — |
| 2026-02-17 | Robert E. Hoffman | Director | A | +156,240 deriv. | — |
| 2026-02-17 | Craig Tendler | Director | A | +156,240 deriv. | — |
| 2026-02-17 | Alan List | Director | A | +156,240 deriv. | — |
| 2026-01-08 | James A. Bianco | Chief Executive Officer | A | +610,332 deriv. | — |
| 2026-01-08 | Dan Dearborn | Chief Financial Officer | A | +273,696 deriv. | — |
| 2025-12-17 | James A. Bianco | Chief Executive Officer | A | +3,414,891 deriv. | — |
| 2025-12-17 | Dan Dearborn | Chief Financial Officer | A | +1,531,367 deriv. | — |
| 2025-03-19 | Craig Tendler | Director | A | +151,883 deriv. | — |
| 2025-01-06 | Alan List | Director | A | +51,275 deriv. | — |
| 2025-01-06 | George K Ng | Director | A | +51,275 deriv. | — |
| 2025-01-06 | Robert E. Hoffman | Director | A | +51,275 deriv. | — |
| 2025-01-06 | James S J Manuso | Director | A | +59,590 deriv. | — |
| 2024-11-14 | James A. Bianco | Chief Executive Officer | A | +1,065,990 deriv. | — |
| 2024-11-14 | Dan Dearborn | Chief Financial Officer | A | +489,848 deriv. | — |
| 2024-10-22 | Dennis Yamashita | Chief Scientific Officer | A | +196,790 deriv. | — |
| 2024-10-22 | James A. Bianco | Chief Executive Officer | A | +2,323,307 | — |
| 2024-10-22 | Alan List | Director | A | +27,106 deriv. | — |
| 2024-10-22 | James S J Manuso | Director | A | +27,106 deriv. | — |
| 2024-10-22 | George K Ng | Director | A | +62,886 deriv. | — |
| 2024-10-22 | Dan Dearborn | Chief Financial Officer | A | +417,401 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| James A. Bianco | Chief Executive Officer | 2,173,307 | $4.43M |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the HURA quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.